Kin Hung Yu
Chief Tech/Sci/R&D Officer bei APOLLOMICS, INC.
Vermögen: 106 648 $ am 31.03.2024
Profil
Kin Hung Yu is currently an Independent Non-Executive Director at STAAR Surgical Co., a Chief Medical Officer at Apollomics, Inc. (United States), and a Chief Medical Officer at Apollomics, Inc. She previously worked as a Director-Clinical Development at ALZA Corp., Assistant Director-Clinical Development at Elan Corp.
Plc, Director-Clinical Development at Johnson & Johnson, Director-Clinical Development at Cassava Sciences, Inc., Assistant Director-Clinical Affairs at Elan Pharmaceuticals LLC, Assistant Director-Clinical Development at Perrigo Co. Plc, Director-Clinical Development at Pain Therapeutics, Inc., Vice President-Clinical Research at Anesiva, Inc., Chief Medical Officer at FibroGen, Inc., and Head-Physical Medicine & Rehabilitation at The Palo Alto Medical Foundation.
Dr. Yu received her undergraduate degree from the University of California, Davis and her doctorate degree from UC Davis School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
STAAR SURGICAL COMPANY
0,01% | 22.04.2024 | 2 786 ( 0,01% ) | 106 648 $ | 31.03.2024 |
Aktive Positionen von Kin Hung Yu
| Unternehmen | Position | Beginn |
|---|---|---|
| STAAR SURGICAL COMPANY | Director/Board Member | 21.01.2021 |
| APOLLOMICS, INC. | Chief Tech/Sci/R&D Officer | 30.03.2023 |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Chief Tech/Sci/R&D Officer | 01.03.2021 |
Ehemalige bekannte Positionen von Kin Hung Yu
| Unternehmen | Position | Ende |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 20.12.2020 |
| ALZA CORPORATION | Chief Tech/Sci/R&D Officer | 01.06.2006 |
| CASSAVA SCIENCES, INC. | Corporate Officer/Principal | 01.07.2004 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.09.2001 |
| PERRIGO COMPANY PLC | Corporate Officer/Principal | - |
Ausbildung von Kin Hung Yu
| University of California, Davis | Undergraduate Degree |
| UC Davis School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| STAAR SURGICAL COMPANY | Health Technology |
| CASSAVA SCIENCES, INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| PERRIGO COMPANY PLC | Health Technology |
| APOLLOMICS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
| The Palo Alto Medical Foundation | Health Services |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
Pain Therapeutics, Inc.
 Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Health Technology |
